Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)
CNY 21.0
(0.92%)
CNY 21.0
(0.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 127.68 Million | 27.72 Million | 16.22 Million | 5.3 Million | 29.42 Million | 37.37 Million |
| Cost of Revenue | 10.85 Million | 70.64 Thousand | 3.07 Million | 3.46 Million | 17.93 Million | 26.34 Million |
| Gross Profit | 116.82 Million | 27.65 Million | 13.14 Million | 1.83 Million | 11.48 Million | 11.03 Million |
| Operating Expenses | 1.17 Billion | 1.01 Billion | 788.93 Million | 658.56 Million | 940.08 Million | 193.9 Million |
| Selling, General and Administrative Expenses | 238.44 Million | 169.67 Million | 117.96 Million | 48.56 Million | 553.21 Million | 9.94 Million |
| Research and Development Expenses | 835.78 Million | 758.61 Million | 622.51 Million | 581.32 Million | 363.04 Million | 169.07 Million |
| Other Expenses | -4.86 Million | 90.76 Million | 48.45 Million | 28.67 Million | 23.82 Million | -303.23 Thousand |
| Cost and Expenses | 1.18 Billion | 1.01 Billion | 792.01 Million | 662.02 Million | 958.02 Million | 220.24 Million |
| Operating Income | -1.05 Billion | -991.39 Million | -775.78 Million | -656.72 Million | -928.59 Million | -236.83 Million |
| Interest Expense | 13.46 Million | 10.29 Million | 6.4 Million | 1.03 Million | 59.4 Thousand | 1.08 Million |
| Income Tax Expense | 3.52 Million | -672.3 Thousand | 808.23 Thousand | 2.52 Million | -709.64 Thousand | 694.27 Thousand |
| Earnings before Tax | -1.05 Billion | -958.12 Million | -772.69 Million | -643.62 Million | -928.93 Million | -237.14 Million |
| Net Income | -1.05 Billion | -957.45 Million | -773.5 Million | -646.14 Million | -928.22 Million | -225.22 Million |
| Earnings Per Share Basic | -2.64 | -2.40 | -1.94 | -1.62 | -2.32 | -0.79 |
| Earnings Per Share Diluted | -2.64 | -2.40 | -1.94 | -1.62 | -2.32 | -0.79 |
| Weighted Average Shares Outstanding | 399.02 Million | 399.6 Million | 399.6 Million | 399.6 Million | 399.6 Million | 284.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 399.02 Million | 399.6 Million | 399.6 Million | 399.6 Million | 399.6 Million | 284.31 Million |
| Gross Margin | 0.91 | 1.00 | 0.81 | 0.35 | 0.39 | 0.30 |
| EBIT Margin | -7.28 | -30.88 | -42.42 | -110.07 | -30.11 | -2.83 |
| Profit Margin | -8.25 | -34.53 | -47.67 | -121.86 | -31.54 | -6.03 |
| EBITDA | -929.77 Million | -856.31 Million | -678.69 Million | -583.63 Million | -881.52 Million | -160.99 Million |
| Earnings Before Tax Margin | -8.25 | -35.75 | -47.81 | -123.86 | -31.56 | -6.34 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 24.33 Million | 47.08 Million | 67.55 Million | 127.68 Million | 28.17 Million | 9.55 Million |
| Cost of Revenue | 4.46 Million | 37.56 Million | 884.46 Thousand | 1.36 Million | 965.7 Thousand | 223.66 Thousand |
| Gross Profit | 19.87 Million | 9.52 Million | 66.67 Million | 126.31 Million | 27.2 Million | 9.32 Million |
| Operating Expenses | 262.43 Million | 239.91 Million | 266.55 Million | 1.18 Billion | 405.88 Million | 276.93 Million |
| Selling, General and Administrative Expenses | 102.49 Million | 118.97 Million | 95.12 Million | - | -67.03 Million | 180.11 Million |
| Research and Development Expenses | 158.88 Million | 116.32 Million | 182.15 Million | - | 341.67 Million | 153.68 Million |
| Other Expenses | -1.06 Million | -4.61 Million | -6.98 | -1.18 Billion | -405.88 Million | 78.02 Thousand |
| Cost and Expenses | 266.9 Million | 277.48 Million | 267.44 Million | 1.18 Billion | 405.88 Million | 277.15 Million |
| Operating Income | -242.56 Million | -230.39 Million | -206.21 Million | -1.05 Billion | -377.7 Million | -260.75 Million |
| Interest Expense | 13.41 Million | 13.46 Million | 12.27 Million | 13.34 Million | 4.6 Million | 3.05 Million |
| Income Tax Expense | 937.25 Thousand | 1.9 Million | -552.14 Thousand | 3.52 Million | 2.94 Million | -915.26 Thousand |
| Earnings before Tax | -248.17 Million | -235.28 Million | -206.21 Million | -1.05 Billion | -379.48 Million | -260.67 Million |
| Net Income | -249.1 Million | -239.32 Million | -205.65 Million | -1.05 Billion | -376.72 Million | -259.76 Million |
| Earnings Per Share Basic | -0.62 | -0.60 | -0.51 | - | -0.94 | -0.65 |
| Earnings Per Share Diluted | -0.62 | -0.60 | -0.51 | - | -0.94 | -0.65 |
| Weighted Average Shares Outstanding | 399.6 Million | 399.6 Million | 403.25 Million | 399.02 Million | 398.99 Million | 399.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 399.6 Million | 399.6 Million | 403.25 Million | 399.02 Million | 398.99 Million | 399.6 Million |
| Gross Margin | 0.82 | 0.20 | 0.99 | 0.99 | 0.97 | 0.98 |
| EBIT Margin | -9.65 | -4.15 | -2.83 | - | -13.05 | -26.76 |
| Profit Margin | -10.23 | -5.08 | -3.04 | -8.25 | -13.37 | -27.20 |
| EBITDA | -234.76 Million | -195.35 Million | -191.25 Million | - | -367.6 Million | -255.52 Million |
| Earnings Before Tax Margin | -9.97 | -4.89 | -3.05 | -8.25 | -13.41 | -27.30 |
8961
603976
CLIS
6284
8750
HPIFY